San Diego, CA - ADA 2017 -  Michael Georgieff MD at the American Diabetes Association's 77th Annual Meeting here today, Saturday June 10, 2017. More than 18,000 physicians, researchers, health care professionals and patient advocates are expected to attend the 77th Annual Meeting which highlights the latest findings in all major areas of the diabetes research and treatment field. Photo by © ADA/Todd Buchanan 2017 Contact Info: todd@medmeetingimages.com

Prof Michael K. Georgieff MD

Paediatrician; Professor, Institute of Child Development, Department of Paediatrics, University of Minnesota Medical School; Co-Director, Masonic Institute for the Developing Brain
Prof Michael K. Georgieff, MD, holds the position of the Martin Lenz Harrison Land Grant Chair in Paediatrics. He is a Professor of Paediatrics, Obstetrics and Gynaecology, and Developmental Psychology, and a Founder and Director of the Masonic Institute for the Developing Brain at the University of Minnesota. He received his MD from Washington University in St. Louis, Missouri. He served his internship, residency and neonatal fellowship at the Children’s Hospital of Philadelphia and a fellowship in neonatology at the University of Minnesota. In addition to caring for patients on the Neonatal Intensive Care Unit, Dr. Georgieff was the Director of the NICU Follow-up Program and the University of Minnesota for 40 years. He has been continuously funded in the field of iron and brain development by the National Institutes of Health for 35 years and has published over 300 scientific articles. He advises the American Academy of Paediatrics, the National Institutes of Health and UNICEF on nutrition and early child development.

More from this expert

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.